HQY icon

HealthEquity

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 40.9%
Negative

Positive
Zacks Investment Research
5 hours ago
Reasons to Add HealthEquity Stock to Your Portfolio for Now
HQY's strong Q2, expanding HSAs and AI-driven efficiencies highlight its growth momentum despite data security risks.
Reasons to Add HealthEquity Stock to Your Portfolio for Now
Neutral
GlobeNewsWire
2 days ago
HealthEquity Introduces GLP-1 Telehealth and Direct HSA Enrollment Platforms
DRAPER, Utah, Oct. 14, 2025 (GLOBE NEWSWIRE) -- HealthEquity , Inc. (Nasdaq: HQY), the nation's largest Health Savings Accounts (HSAs) and consumer-directed benefits administrator, today announced two consumer-focused initiatives designed to expand access to affordable healthcare solutions for millions of American families: a curated platform connecting HealthEquity HSA members with affordable healthcare solutions beginning with GLP-1 weight management medications, and a direct HSA enrollment platform. The new offerings coincide with National HSA Awareness Day and the start of open enrollment season.
HealthEquity Introduces GLP-1 Telehealth and Direct HSA Enrollment Platforms
Positive
Zacks Investment Research
20 days ago
Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term
Neutral
GlobeNewsWire
21 days ago
HealthEquity Strengthens Executive Leadership Team with Strategic Appointments to Drive Growth and Innovation
DRAPER, Utah, Sept. 25, 2025 (GLOBE NEWSWIRE) -- HealthEquity , Inc. (Nasdaq: HQY), the nation's largest Health Savings Accounts (HSAs) and consumer-directed benefits administrator, today announced the appointment of new senior executives to accelerate the company's strategic vision and capitalize on expanding market opportunities.
HealthEquity Strengthens Executive Leadership Team with Strategic Appointments to Drive Growth and Innovation
Positive
Zacks Investment Research
23 days ago
Why HealthEquity (HQY) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why HealthEquity (HQY) is a Top Momentum Stock for the Long-Term
Positive
Zacks Investment Research
1 month ago
Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term
Positive
Seeking Alpha
1 month ago
HealthEquity: Swing Trading Stock With A Beat And Raise
HealthEquity reported strong Q2 results with revenue and earnings beats, but valuation remains stretched, justifying a neutral-to-cautiously bullish rating. The company operates in a large, growing healthcare savings market, with solid account and asset growth driven mostly by organic expansion. Financial metrics were robust: revenue up 8.6%, adjusted EBITDA up 18%, and margin expansion, with continued share repurchases but no dividend yet.
HealthEquity: Swing Trading Stock With A Beat And Raise
Positive
Zacks Investment Research
1 month ago
HealthEquity Stock Gains as Q2 Earnings Beat Estimates, Revenues Up Y/Y
HQY's Q2 results reflect EPS growth of 25.6% year over year, revenue growth of 8.6% and a 12% increase in HSA. The company also updates its fiscal 2026 guidance.
HealthEquity Stock Gains as Q2 Earnings Beat Estimates, Revenues Up Y/Y
Neutral
Seeking Alpha
1 month ago
HealthEquity, Inc. (HQY) Q2 2026 Earnings Call Transcript
HealthEquity, Inc. (NASDAQ:HQY ) Q2 2026 Earnings Call September 2, 2025 4:30 PM EDT Company Participants Richard Putnam - Vice President of Investor Relations Scott Cutler - CEO, President & Director Stephen D. Neeleman - Founder & Vice Chairman James Lucania - CFO & Executive VP Conference Call Participants Brian Tanquilut - Jefferies LLC, Research Division Charles Peters - Raymond James & Associates, Inc., Research Division Scott Schoenhaus - KeyBanc Capital Markets Inc., Research Division George Hill - Deutsche Bank AG, Research Division Allen Lutz - BofA Securities, Research Division Mark Marcon - Robert W.
HealthEquity, Inc. (HQY) Q2 2026 Earnings Call Transcript
Positive
Zacks Investment Research
1 month ago
Compared to Estimates, HealthEquity (HQY) Q2 Earnings: A Look at Key Metrics
Although the revenue and EPS for HealthEquity (HQY) give a sense of how its business performed in the quarter ended July 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Compared to Estimates, HealthEquity (HQY) Q2 Earnings: A Look at Key Metrics